Earnings Call · Q3 FY2023·2023-11-06

Q3 23EPS +62.50%·Rev n/aQ2 23EPS +11.11%·Rev n/aQ1 23EPS -10.53%·Rev n/aQ4 22EPS +25.00%·Rev n/a⚠ consensus missing

MYRIAD GENETICS INC MYGN

Matt Scalo — Investor Relations or IR Representative

Paul Diaz — Chief Executive Officer

Mark Verratti — Chief Commercial Officer

Bryan Riggsbee — Chief Financial Officer

+8.7%1d on move date+8.4% vs SPY3d−0.3%5d+0.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MYGN calls or request research access.

More MYGN calls Browse calls Request research access